SCHEMBL3976593

SCHEMBL3976593

NC(=O)c1ccc(-c2ccccc2F)c(OCCBr)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP10 Q53GL7 3/20 0.42
MAOB P27338 1/20 0.42
PARP15 Q460N3 1/20 0.42
PARP14 Q460N5 1/20 0.42
PTGER1 P34995 2/20 0.40
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
ALDH1A1 P00352 1/20 0.39
MAPT P10636 1/20 0.39
FEN1 P39748 1/20 0.39
NLRP3 Q96P20 1/20 0.39
PDK2 Q15119 1/20 0.39
SLC6A9 P48067 1/20 0.38
MAPK1 P28482 1/20 0.38
PDE4D Q08499 1/20 0.37
RORC P51449 2/20 0.37
CCNE2 O96020 1/20 0.37
CCNE1 P24864 1/20 0.37
CDK2 P24941 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3975202 0.87 PARP10 (0.42) PARP10MAOBPARP15PARP14PTGER1
SCHEMBL3974889 0.83 MKNK1 (0.47) PARP10RAB9AL3MBTL1ALDH1A1MAPK1
SCHEMBL3972289 0.76 MKNK1 (0.46) PARP10RAB9AL3MBTL1ALDH1A1MAPK1
SCHEMBL1789903 0.72 PTGS2 (0.46) PARP10MAOBPARP15PARP14FEN1
SCHEMBL3973587 0.70 MKNK1 (0.48) PARP10RAB9AL3MBTL1ALDH1A1MAPK1
SCHEMBL1785895 0.70 FFAR4 (0.51) PARP10MAOBPARP15PARP14
SCHEMBL3973609 0.69 MKNK1 (0.47) PARP10RAB9AL3MBTL1ALDH1A1MAPK1
SCHEMBL17485155 0.69 AR (0.51) PARP10PTGER1RAB9AL3MBTL1ALDH1A1
SCHEMBL27873075 0.68 MAPT (0.58) NPC1RAB9AL3MBTL1ALDH1A1MAPT
SCHEMBL11541429 0.67 L3MBTL1 (0.49) RAB9AL3MBTL1ALDH1A1MAPTPDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2054383-A2 NOVEL COMPOUNDS AS ANTAGONISTS OR INVERSE AGONISTS AT OPIOID RECEPTORS SmithKline Beecham Corporation (US) 2009-05-06 EP disclosed
WO-2008021849-A2 NOVEL COMPOUNDS AS ANTAGONISTS OR INVERSE AGONISTS AT OPIOID RECEPTORS SMITHKLINE BEECHAM CORPORATION (US) 2008-02-21 WO disclosed